Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_provenance.
- NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_assertion description "[Taken together, results obtained from in vitro studies indicate that therapeutic targeting of CXCR2 might aid in lowering A? levels in the AD brain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_provenance.
- NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_assertion evidence source_evidence_literature NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_provenance.
- NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_assertion SIO_000772 21084199 NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_provenance.
- NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_assertion wasDerivedFrom befree-20140225 NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_provenance.
- NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_assertion wasGeneratedBy ECO_0000203 NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_provenance.